Tag: Ophthalmic solutions

Developed in the 1930s, EDTA is a versatile chelating agent used in medicine for various purposes. Find out **what medications contain EDTA**, serving as a therapeutic ingredient for heavy metal toxicity or a preservative to enhance drug stability.

While the brand name Isopto Homatropine has been discontinued in the U.S., the question of 'Has homatropine been discontinued?' is complex, as generic versions may still be available [1.2.1, 1.3.1, 1.4.1]. This medication belongs to a class of drugs called mydriatics, used to dilate the pupil.

Globally, in 2020, glaucoma alone was responsible for the blindness of 3.61 million people [1.3.6]. So, what medication is used to treat eye problems like this and many others? From simple lubricating drops to advanced biologic injections, the options are extensive.

Over 100 million eye exams involving pupil dilation are performed in the United States each year [1.10.1]. While essential for diagnosis, the lingering effects lead many to ask: what can reverse pupil dilation and restore normal vision faster?

The average retail price for a 7.5mL bottle of 1% trifluridine ophthalmic solution is approximately $364.38, though prices can be as low as $61.64 with coupons [1.2.1, 1.4.1]. This article explores the question: **how much does trifluridine ophthalmic solution cost** and why?

According to the U.S. Food and Drug Administration (FDA) approvals, there is currently no generic version available for the prescription eye drop Perfluorohexyloctane. The brand-name medication, marketed as Miebo, is the only formulation available for this specific drug, used to treat the signs and symptoms of dry eye disease.

Dry eye disease (DED) affects at least 16 million Americans, with potentially millions more undiagnosed. When considering treatment, a key question for many is: **Is Miebo more effective than Restasis?** This article compares these two leading prescription medications.

The voluntary withdrawal of Lumigan 0.03% bimatoprost ophthalmic solution in 2012 puzzled many patients, especially since the drug had proven effective in treating glaucoma. This decision by manufacturer Allergan was not due to a recall or safety issues but was instead a strategic move to focus exclusively on a more advanced, and better-tolerated, formulation. The development of the 0.01% solution offered the same efficacy with a lower incidence of a common side effect.

Dry eye is a common condition that can occur if your eye doesn't produce enough tears or produces poor-quality tears [1.6]. The combination of **what is polyvinyl alcohol povidone** in ophthalmic solutions offers a widely used, effective treatment for providing moisture and comfort.